AMPH Dividend: Amphastar Pharmaceuticals Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

AMPH Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	722	731	644	499	437	349
Revenue Growth (YoY)	1%	14%	28.99%	14%	25%	8%
Cost of Revenue	362	358	290	250	238	206
Gross Profit	360	373	353	248	199	143
Selling, General & Admin	99	94	80	66	68	65
Research & Development	65	61	63	64	49	57
Operating Expenses	178	168	154	141	129	132
Other Non Operating Income (Expenses)	-2	4	-3	14	0	-6
Pretax Income	161	189	171	116	84	4
Income Tax Expense	27	29	31	23	20	3
Net Income	134	159	137	91	62	1
Net Income Growth	-19%	16%	51%	47%	6,100%	-98%
Shares Outstanding (Diluted)	48.12	52.05	53	52.4	49.8	49.1
Shares Change (YoY)	-8%	-2%	1%	5%	1%	-2%
EPS (Diluted)	2.79	3.06	2.59	1.74	1.25	0.03
EPS Growth	-13%	18%	49%	39%	4,067%	-97%
Free Cash Flow	109	172	145	65	70	23
Free Cash Flow Per Share	2.26	3.3	2.73	1.24	1.4	0.46
Gross Margin	49.86%	51.02%	54.81%	49.69%	45.53%	40.97%
Operating Margin	25.06%	28.04%	30.9%	21.44%	15.78%	3.15%
Profit Margin	18.55%	21.75%	21.27%	18.23%	14.18%	0.28%
Free Cash Flow Margin	15.09%	23.52%	22.51%	13.02%	16.01%	6.59%
EBITDA	234	217	208	117	80	21
EBITDA Margin	32.4%	29.68%	32.29%	23.44%	18.3%	6.01%
D&A For EBITDA	53	12	9	10	11	10
EBIT	181	205	199	107	69	11
EBIT Margin	25.06%	28.04%	30.9%	21.44%	15.78%	3.15%
Effective Tax Rate	16.77%	15.34%	18.12%	19.82%	23.8%	75%